https://www.selleckchem.com/GSK-3.html
In this review article, we will provide a critical overview of the MS-based approaches that can be employed to study histone PTMs and variants in clinical samples, with a strong focus on the latest advances in this area, such as the analysis of uncommon modifications and the integration of epi-proteomics data into multi-OMICs approaches, as well as the challenges to be addressed to fully exploit the potential of this novel field of research.Pharmaceutical industry funding of patient organizations raises ethical challenges related to patient engage
Like
Comment
Share
